Sector News

Bayer to cut 200 jobs at U.S. logistics center

February 22, 2019
Life sciences

Add a Bayer Healthcare logistics center in Indiana to U.S. operations that will get whacked as part of a major restructuring that will hive off its animal health unit and shed about 12,000 jobs.

The German company this week told about 195 employees at the center in Mishawaka that the operation will be closed over the next 18 months.

Bayer spokesman Chris Loder said in an email today that the decision to close the Indiana site was part of its effort to transition toward an integrated global organization and increase efficiency.

“Most of the employees at the Mishawaka/Edison Lakes site are part of Bayer’s customer logistics service center, which is responsible for the end-to-end customer experience—from the starting point of taking customer orders, through to delivery and final payment—for our Consumer Health and Pharmaceuticals businesses.”

The German conglomerate has already announced other closings across its diverse organization. It has said that it will close its hemophilia manufacturing facility in Wuppertal, Germany, and lay off 350 workers, focusing all of its recombinant factor VIII production at its site in Berkeley, California. The cuts in Germany came on top of the announced layoffs in October of more than 225 manufacturing workers in Berkeley.

Last month, it said it was closing an operations center in Robinson, Pennsylvania, near Pittsburgh, that was part of its decision to consolidate business functions. The cuts mean the loss of 569 Bayer employees and 96 contractors over the next two years. Other cuts include a decision to divest its animal health business and to shed part of its consumer health franchise—along with 1,100 jobs in the sector. It also will trim 4,100 crop science positions as it integrates its newly acquired Monsanto operations.

By Eric Palmer

Source: Fierce Pharma

comments closed

Related News

January 29, 2023

Colorcon, Inc. signs Put agreement with intent to acquire controlled atmosphere packaging specialist Airnov Healthcare Packaging

Life sciences

Airnov provides critical healthcare industries with high-quality, controlled atmosphere packaging, to protect their products from moisture and oxygen. The business has manufacturing facilities in the USA, France, China and India and employs around 700 people.

January 29, 2023

Takeda pledges up to $1.13B for rights to Hutchmed’s cancer drug fruquintinib outside of China

Life sciences

Takeda of Japan has partnered with Hong Kong-based Hutchmed, gaining the commercial rights to colorectal cancer drug fruquintinib outside of China for $400 million up front, plus $730 million in potential milestone payments. Takeda also will help develop fruquintinib, which can be applied to subtypes of refractory metastatic colorectal cancer, regardless of biomarker status, the companies said.

January 29, 2023

Vir taps Bayer dealmaker Marianne De Backer as its next CEO

Life sciences

On April 3, Scangos, who’s been chief executive officer at Vir since the start of 2017, will hand over the reins to Marianne De Backer, Ph.D. De Backer comes over from Bayer, where she currently heads up pharmaceutical strategy, business development and licensing. Alongside her CEO appointment, De Backer is set to join Vir’s board of directors, the company said Wednesday.

How can we help you?

We're easy to reach